News|Articles|July 2, 2003
- Pharmaceutical Technology-07-02-2003
- Volume 27
- Issue 7
Capacity Worries Fade for Biomanufacturing
Author(s)Jim Miller
The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.
Advertisement
Articles in this issue
about 23 years ago
July 2003about 23 years ago
The Push for Generics Challenges Manufacturersabout 23 years ago
Emerging Research Opportunities in Oral Inhalation Technologyabout 23 years ago
Preventing Metal ContaminationAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
2
Can Predictive Modelling Fix Fragmented Pharma Development Data?
3
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
4
Pharma's Next AI Problem Is Authority
5